Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03257111 · ClinicalTrials.gov registry record
Activity Levels and Rehabilitation Outcomes of Patients Post-stroke
A clinical trial, sponsored by Florida Gulf Coast University.
- Completed
- Registry status
- 120
- Enrollment target
NCT03257111: Completed study, sponsored by Florida Gulf Coast University.
NCT03257111 is a clinical trial that has completed, run by Florida Gulf Coast University. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03257111 has completed, sponsored by Florida Gulf Coast University.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
Patients admitted to the in-patient rehabilitation center with a diagnosis of stroke will be recruited into the study. The participants will wear two activity monitors (one commercial grade and one research grade) for the duration of their rehab stay. Data from the monitors will be correlated with rehab outcomes, therapy units billed, and length of stay.
Primary Outcome
Amount of physical activity each day and throughout rehab stay as measured by 2 activity monitors beginning at admission and ending at discharge from the facility
Interventions
- OTHER activity monitors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-07-12 |
| Est. Completion | 2020-07-21 |
What the finished NCT03257111 record still lists
NCT03257111 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which activity monitors is the first listed.
NCT03257111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03257111 about?
NCT03257111 is a clinical study titled "Activity Levels and Rehabilitation Outcomes of Patients Post-stroke". Patients admitted to the in-patient rehabilitation center with a diagnosis of stroke will be recruited into the study. The participants will wear two activity monitors (one commercial grade and one research grade) for the duration of their rehab stay. Data from the monitors will be correlated with r...
What is the current status of trial NCT03257111?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2017-07-12. Estimated completion is 2020-07-21.
What interventions are being tested in trial NCT03257111?
The interventions under investigation include: activity monitors (OTHER).
Who is sponsoring clinical trial NCT03257111?
This trial is sponsored by Florida Gulf Coast University, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI